Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2009

AUTHORS

Oscar B Goodman, Matthew I Milowsky, Jodi Kaplan, Maha Hussain, David M Nanus

ABSTRACT

INTRODUCTION: Targeted therapies may impact the natural history of bladder cancer based upon their pharmacokinetics. The Her2/neu receptor tyrosine kinase, overexpressed by half of all primary urothelial carcinomas, has recently been examined as a therapeutic target in bladder cancer in a prospective phase II multicenter trial (NCI-198) that enrolled 109 patients with advanced bladder carcinomas for treatment with trastuzumab in combination with paclitaxel, carboplatin, and gemcitabine. We report on documented isolated Her2/neu positive carcinomatous meningitis in a patient treated with trastuzumab. CASE PRESENTATION: A 61-year-old Caucasian man with metastatic bladder cancer was treated with neoadjuvant chemotherapy in combination with trastuzumab with a partial response that was followed by a complete response after surgery. He relapsed with isolated Her2/neu positive carcinomatous meningitis. CONCLUSION: Carcinomatous meningitis in bladder cancer is extremely rare. This is the first case reported of Her2/neu positive carcinomatous meningitis. Disease recurred solely at a sanctuary site, demonstrating that despite the systemic efficacy of trastuzumab in combination with chemotherapy, its inability to enter the central nervous system potentially contributes to the unusual site of disease recurrence. More... »

PAGES

9110-9110

Identifiers

URI

http://scigraph.springernature.com/pub.10.4076/1752-1947-3-9110

DOI

http://dx.doi.org/10.4076/1752-1947-3-9110

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1051435379

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19918289


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "UC San Diego Health System", 
          "id": "https://www.grid.ac/institutes/grid.420234.3", 
          "name": [
            "Division of Clinical Oncology, Nevada Cancer Institute, Las Vegas, NV 89135, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goodman", 
        "givenName": "Oscar B", 
        "id": "sg:person.0610612224.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610612224.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "NewYork\u2013Presbyterian Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413734.6", 
          "name": [
            "Division of Hematology and Medical Oncology, Department of Medicine, Weill Medical College of Cornell University \u2013 New York Presbyterian Hospital, New York, NY 10021, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Milowsky", 
        "givenName": "Matthew I", 
        "id": "sg:person.014641236037.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014641236037.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "NewYork\u2013Presbyterian Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413734.6", 
          "name": [
            "Division of Hematology and Medical Oncology, Department of Medicine, Weill Medical College of Cornell University \u2013 New York Presbyterian Hospital, New York, NY 10021, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaplan", 
        "givenName": "Jodi", 
        "id": "sg:person.01244437304.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244437304.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Michigan\u2013Ann Arbor", 
          "id": "https://www.grid.ac/institutes/grid.214458.e", 
          "name": [
            "Division of Hematology and Medical Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI 48109, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hussain", 
        "givenName": "Maha", 
        "id": "sg:person.07656144757.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07656144757.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "NewYork\u2013Presbyterian Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413734.6", 
          "name": [
            "Division of Hematology and Medical Oncology, Department of Medicine, Weill Medical College of Cornell University \u2013 New York Presbyterian Hospital, New York, NY 10021, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nanus", 
        "givenName": "David M", 
        "id": "sg:person.0666217770.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666217770.24"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.bbcan.2006.06.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008590871"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1995.146", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016467825", 
          "https://doi.org/10.1038/bjc.1995.146"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1995.146", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016467825", 
          "https://doi.org/10.1038/bjc.1995.146"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.urology.2003.10.040", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016996819"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00686480", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018531913", 
          "https://doi.org/10.1007/bf00686480"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00686480", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018531913", 
          "https://doi.org/10.1007/bf00686480"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.urology.2005.01.046", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018929405"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.urology.2005.01.046", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018929405"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5980/jpnjurol1989.95.817", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024921273"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.07.757", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028324313"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.07.757", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028324313"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19930715)72:2<553::aid-cncr2820720236>3.0.co;2-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031408219"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/92.3.205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032301848"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.10731", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034586643"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002800000253", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041926738", 
          "https://doi.org/10.1007/s002800000253"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.08.0994", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047592423"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/stem.150001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050926945"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/stem.150001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050926945"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2003.08.027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051514027"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2002.04.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064202968"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2000.18.11.2349", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074645689"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2000.18.17.3068", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074702294"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074847508", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074859829", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079043989", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082541064", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009", 
    "datePublishedReg": "2009-01-01", 
    "description": "INTRODUCTION: Targeted therapies may impact the natural history of bladder cancer based upon their pharmacokinetics. The Her2/neu receptor tyrosine kinase, overexpressed by half of all primary urothelial carcinomas, has recently been examined as a therapeutic target in bladder cancer in a prospective phase II multicenter trial (NCI-198) that enrolled 109 patients with advanced bladder carcinomas for treatment with trastuzumab in combination with paclitaxel, carboplatin, and gemcitabine. We report on documented isolated Her2/neu positive carcinomatous meningitis in a patient treated with trastuzumab.\nCASE PRESENTATION: A 61-year-old Caucasian man with metastatic bladder cancer was treated with neoadjuvant chemotherapy in combination with trastuzumab with a partial response that was followed by a complete response after surgery. He relapsed with isolated Her2/neu positive carcinomatous meningitis.\nCONCLUSION: Carcinomatous meningitis in bladder cancer is extremely rare. This is the first case reported of Her2/neu positive carcinomatous meningitis. Disease recurred solely at a sanctuary site, demonstrating that despite the systemic efficacy of trastuzumab in combination with chemotherapy, its inability to enter the central nervous system potentially contributes to the unusual site of disease recurrence.", 
    "genre": "research_article", 
    "id": "sg:pub.10.4076/1752-1947-3-9110", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1038062", 
        "issn": [
          "1752-1947"
        ], 
        "name": "Journal of Medical Case Reports", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "3"
      }
    ], 
    "name": "Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literature", 
    "pagination": "9110-9110", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "f504353233d6ec15305a7e45137f51fe6cf59e1f60508ed562df530b4322aba2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19918289"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101293382"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.4076/1752-1947-3-9110"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1051435379"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.4076/1752-1947-3-9110", 
      "https://app.dimensions.ai/details/publication/pub.1051435379"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T16:48", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8669_00000547.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767151/"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.4076/1752-1947-3-9110'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.4076/1752-1947-3-9110'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.4076/1752-1947-3-9110'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.4076/1752-1947-3-9110'


 

This table displays all metadata directly associated to this object as RDF triples.

164 TRIPLES      21 PREDICATES      50 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.4076/1752-1947-3-9110 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N865d50d0524a4a23864ccd8796da0b61
4 schema:citation sg:pub.10.1007/bf00686480
5 sg:pub.10.1007/s002800000253
6 sg:pub.10.1038/bjc.1995.146
7 https://app.dimensions.ai/details/publication/pub.1074847508
8 https://app.dimensions.ai/details/publication/pub.1074859829
9 https://app.dimensions.ai/details/publication/pub.1079043989
10 https://app.dimensions.ai/details/publication/pub.1082541064
11 https://doi.org/10.1002/1097-0142(19930715)72:2<553::aid-cncr2820720236>3.0.co;2-z
12 https://doi.org/10.1002/ijc.10731
13 https://doi.org/10.1002/stem.150001
14 https://doi.org/10.1016/j.bbcan.2006.06.001
15 https://doi.org/10.1016/j.ejca.2003.08.027
16 https://doi.org/10.1016/j.urology.2003.10.040
17 https://doi.org/10.1016/j.urology.2005.01.046
18 https://doi.org/10.1093/jnci/92.3.205
19 https://doi.org/10.1200/jco.2000.18.11.2349
20 https://doi.org/10.1200/jco.2000.18.17.3068
21 https://doi.org/10.1200/jco.2002.04.016
22 https://doi.org/10.1200/jco.2005.07.757
23 https://doi.org/10.1200/jco.2006.08.0994
24 https://doi.org/10.5980/jpnjurol1989.95.817
25 schema:datePublished 2009
26 schema:datePublishedReg 2009-01-01
27 schema:description INTRODUCTION: Targeted therapies may impact the natural history of bladder cancer based upon their pharmacokinetics. The Her2/neu receptor tyrosine kinase, overexpressed by half of all primary urothelial carcinomas, has recently been examined as a therapeutic target in bladder cancer in a prospective phase II multicenter trial (NCI-198) that enrolled 109 patients with advanced bladder carcinomas for treatment with trastuzumab in combination with paclitaxel, carboplatin, and gemcitabine. We report on documented isolated Her2/neu positive carcinomatous meningitis in a patient treated with trastuzumab. CASE PRESENTATION: A 61-year-old Caucasian man with metastatic bladder cancer was treated with neoadjuvant chemotherapy in combination with trastuzumab with a partial response that was followed by a complete response after surgery. He relapsed with isolated Her2/neu positive carcinomatous meningitis. CONCLUSION: Carcinomatous meningitis in bladder cancer is extremely rare. This is the first case reported of Her2/neu positive carcinomatous meningitis. Disease recurred solely at a sanctuary site, demonstrating that despite the systemic efficacy of trastuzumab in combination with chemotherapy, its inability to enter the central nervous system potentially contributes to the unusual site of disease recurrence.
28 schema:genre research_article
29 schema:inLanguage en
30 schema:isAccessibleForFree true
31 schema:isPartOf N2278e9739fa543f5a31f3282d4c91bdc
32 Ne096ed88379c4204a35f398d6d635106
33 sg:journal.1038062
34 schema:name Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literature
35 schema:pagination 9110-9110
36 schema:productId N02a7d38b30ac467da396bc452bf88f9b
37 N7a2db2cb48cc4e3a96cff1a5da3e69b1
38 Nc4113389f2224fb3894b82cf422a8a9e
39 Nca8196e46c834e30aa29bb66f547876e
40 Nea42d43851964afe8046597a62831fef
41 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051435379
42 https://doi.org/10.4076/1752-1947-3-9110
43 schema:sdDatePublished 2019-04-10T16:48
44 schema:sdLicense https://scigraph.springernature.com/explorer/license/
45 schema:sdPublisher N26b2892bb4594f94b74a953d3ba947bb
46 schema:url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767151/
47 sgo:license sg:explorer/license/
48 sgo:sdDataset articles
49 rdf:type schema:ScholarlyArticle
50 N00374049f1c64d71ab0df64e3c1136c0 rdf:first sg:person.07656144757.10
51 rdf:rest N66dd9ad9e20a432a97938d02c1df28c7
52 N02a7d38b30ac467da396bc452bf88f9b schema:name pubmed_id
53 schema:value 19918289
54 rdf:type schema:PropertyValue
55 N1d720a37769847f3ad3792c8da8db3a5 rdf:first sg:person.01244437304.19
56 rdf:rest N00374049f1c64d71ab0df64e3c1136c0
57 N2278e9739fa543f5a31f3282d4c91bdc schema:volumeNumber 3
58 rdf:type schema:PublicationVolume
59 N26b2892bb4594f94b74a953d3ba947bb schema:name Springer Nature - SN SciGraph project
60 rdf:type schema:Organization
61 N66dd9ad9e20a432a97938d02c1df28c7 rdf:first sg:person.0666217770.24
62 rdf:rest rdf:nil
63 N7a2db2cb48cc4e3a96cff1a5da3e69b1 schema:name dimensions_id
64 schema:value pub.1051435379
65 rdf:type schema:PropertyValue
66 N82f05236e5bf445cb7a9566151917019 rdf:first sg:person.014641236037.41
67 rdf:rest N1d720a37769847f3ad3792c8da8db3a5
68 N865d50d0524a4a23864ccd8796da0b61 rdf:first sg:person.0610612224.38
69 rdf:rest N82f05236e5bf445cb7a9566151917019
70 Nc4113389f2224fb3894b82cf422a8a9e schema:name readcube_id
71 schema:value f504353233d6ec15305a7e45137f51fe6cf59e1f60508ed562df530b4322aba2
72 rdf:type schema:PropertyValue
73 Nca8196e46c834e30aa29bb66f547876e schema:name doi
74 schema:value 10.4076/1752-1947-3-9110
75 rdf:type schema:PropertyValue
76 Ne096ed88379c4204a35f398d6d635106 schema:issueNumber 1
77 rdf:type schema:PublicationIssue
78 Nea42d43851964afe8046597a62831fef schema:name nlm_unique_id
79 schema:value 101293382
80 rdf:type schema:PropertyValue
81 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
82 schema:name Medical and Health Sciences
83 rdf:type schema:DefinedTerm
84 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
85 schema:name Oncology and Carcinogenesis
86 rdf:type schema:DefinedTerm
87 sg:journal.1038062 schema:issn 1752-1947
88 schema:name Journal of Medical Case Reports
89 rdf:type schema:Periodical
90 sg:person.01244437304.19 schema:affiliation https://www.grid.ac/institutes/grid.413734.6
91 schema:familyName Kaplan
92 schema:givenName Jodi
93 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244437304.19
94 rdf:type schema:Person
95 sg:person.014641236037.41 schema:affiliation https://www.grid.ac/institutes/grid.413734.6
96 schema:familyName Milowsky
97 schema:givenName Matthew I
98 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014641236037.41
99 rdf:type schema:Person
100 sg:person.0610612224.38 schema:affiliation https://www.grid.ac/institutes/grid.420234.3
101 schema:familyName Goodman
102 schema:givenName Oscar B
103 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610612224.38
104 rdf:type schema:Person
105 sg:person.0666217770.24 schema:affiliation https://www.grid.ac/institutes/grid.413734.6
106 schema:familyName Nanus
107 schema:givenName David M
108 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666217770.24
109 rdf:type schema:Person
110 sg:person.07656144757.10 schema:affiliation https://www.grid.ac/institutes/grid.214458.e
111 schema:familyName Hussain
112 schema:givenName Maha
113 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07656144757.10
114 rdf:type schema:Person
115 sg:pub.10.1007/bf00686480 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018531913
116 https://doi.org/10.1007/bf00686480
117 rdf:type schema:CreativeWork
118 sg:pub.10.1007/s002800000253 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041926738
119 https://doi.org/10.1007/s002800000253
120 rdf:type schema:CreativeWork
121 sg:pub.10.1038/bjc.1995.146 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016467825
122 https://doi.org/10.1038/bjc.1995.146
123 rdf:type schema:CreativeWork
124 https://app.dimensions.ai/details/publication/pub.1074847508 schema:CreativeWork
125 https://app.dimensions.ai/details/publication/pub.1074859829 schema:CreativeWork
126 https://app.dimensions.ai/details/publication/pub.1079043989 schema:CreativeWork
127 https://app.dimensions.ai/details/publication/pub.1082541064 schema:CreativeWork
128 https://doi.org/10.1002/1097-0142(19930715)72:2<553::aid-cncr2820720236>3.0.co;2-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1031408219
129 rdf:type schema:CreativeWork
130 https://doi.org/10.1002/ijc.10731 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034586643
131 rdf:type schema:CreativeWork
132 https://doi.org/10.1002/stem.150001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050926945
133 rdf:type schema:CreativeWork
134 https://doi.org/10.1016/j.bbcan.2006.06.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008590871
135 rdf:type schema:CreativeWork
136 https://doi.org/10.1016/j.ejca.2003.08.027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051514027
137 rdf:type schema:CreativeWork
138 https://doi.org/10.1016/j.urology.2003.10.040 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016996819
139 rdf:type schema:CreativeWork
140 https://doi.org/10.1016/j.urology.2005.01.046 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018929405
141 rdf:type schema:CreativeWork
142 https://doi.org/10.1093/jnci/92.3.205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032301848
143 rdf:type schema:CreativeWork
144 https://doi.org/10.1200/jco.2000.18.11.2349 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074645689
145 rdf:type schema:CreativeWork
146 https://doi.org/10.1200/jco.2000.18.17.3068 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074702294
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1200/jco.2002.04.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064202968
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1200/jco.2005.07.757 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028324313
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1200/jco.2006.08.0994 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047592423
153 rdf:type schema:CreativeWork
154 https://doi.org/10.5980/jpnjurol1989.95.817 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024921273
155 rdf:type schema:CreativeWork
156 https://www.grid.ac/institutes/grid.214458.e schema:alternateName University of Michigan–Ann Arbor
157 schema:name Division of Hematology and Medical Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI 48109, USA
158 rdf:type schema:Organization
159 https://www.grid.ac/institutes/grid.413734.6 schema:alternateName NewYork–Presbyterian Hospital
160 schema:name Division of Hematology and Medical Oncology, Department of Medicine, Weill Medical College of Cornell University – New York Presbyterian Hospital, New York, NY 10021, USA
161 rdf:type schema:Organization
162 https://www.grid.ac/institutes/grid.420234.3 schema:alternateName UC San Diego Health System
163 schema:name Division of Clinical Oncology, Nevada Cancer Institute, Las Vegas, NV 89135, USA
164 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...